Vaccination can provide a safe alternative to chemotherapy by using the body's natural
defense mechanisms to create a potent immune response against tumor cells. Peptide …

Vaccine candidates for the treatment of human papillomavirus (HPV)-associated cancers
are aimed to activate T-cells and induce development of cytotoxic anti-tumor specific …

The aim of the present study was to improve the immunogenicity of peptide epitope vaccines
using novel nanocarriers based on self-assembling materials. Several studies demonstrated …

Immunotherapy is one of the most promising strategies for the treatment of cancer. Human
papillomavirus (HPV) is responsible for virtually all cases of cervical cancer. The main …

Many cancer vaccines are not successful in clinical trials, mainly due to the challenges
associated with breaking immune tolerance. Herein, we report a new strategy using an …

Peptide vaccines have shown great potential in cancer immunotherapy by targeting tumor
antigens and activating the patient's immune system to mount a specific response against …

Peptide-based vaccines have been proposed as a therapeutic strategy for many infectious
diseases, including human papilloma virus (HPV)-related cervical cancer. Peptide-based …

Cancer vaccines designed to initiate or amplify tumor-specific T-cell responses have been
used as a key approach for effective cancer immunotherapy. Across the history of tumor …

Peptide vaccines exhibit great potential in cancer therapy via eliciting antigen-specific host
immune response and long-term immune memory to defend cancer cells. However, the low …

Peptide vaccines are used in clinical cancer immunotherapy, however, they generally suffer
from suboptimal immunogenicity compared to live or inactive virus vector vaccines or …